Jérémie Neasta

Dr. Jérémie Neasta


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CMCéline M’kadmi
Céline M’kadmi
ACAgustina Cabral
Agustina Cabral
FBFranco Barrile
Franco Barrile
JGJulien Giribaldi
Julien Giribaldi
SCSonia Cantel
Sonia Cantel
JFJean-alain Fehrentz
Jean-alain Fehrentz

23 June 2013 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
SBSegev Barak
Segev Barak
FLFeng Liu
Feng Liu
SHSami Ben Hamida
Sami Ben Hamida
QYQuinn V Yowell
Quinn V Yowell
JNJérémie Neasta
Jérémie Neasta
DRDorit Ron
Dorit Ron
The authors show that reconsolidation of alcohol-related memories activates mammalian target of rapamycin complex 1 (mTORC1) in select amygdalar and cortical regions and systemic or central amygdalar inhibition of mTORC1 during reconsolidation disrupts alcohol-associated memories, leading to a long-lasting suppression of relapse, suggesting a potential therapeutic target to prevent relapse. Relapse to alcohol abuse is an important clinical issue that is frequently caused by cue-induced drug craving. Therefore, disruption of the memory for the cue-alcohol association is expected to prevent relapse. It is increasingly accepted that memories become labile and erasable soon after their reactivation through retrieval during a memory reconsolidation process that depends on protein synthesis. Here we show that reconsolidation of alcohol-related memories triggered by the sensory properties of alcohol itself (odor and taste) activates mammalian target of rapamycin complex 1 (mTORC1) in select amygdalar and cortical regions in rats, resulting in increased levels of several synaptic proteins. Furthermore, systemic or central amygdalar inhibition of mTORC1 during reconsolidation disrupts alcohol-associated memories, leading to a long-lasting suppression of relapse. Our findings provide evidence that the mTORC1 pathway and its downstream substrates are crucial in alcohol-related memory reconsolidation and highlight this pathway as a therapeutic target to prevent relapse.

16 November 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JNJérémie Neasta
Jérémie Neasta
SHSami Ben Hamida
Sami Ben Hamida
QYQuinn Yowell
Quinn Yowell
SCSebastien Carnicella
Sebastien Carnicella
DRDorit Ron
Dorit Ron
Alcohol addiction is a chronically relapsing disorder that includes certain maladaptive learning and memory. The serine and threonine kinase complex, mammalian target of rapamycin complex 1 (mTORC1), has been implicated in synaptic plasticity, learning, and memory by controlling protein translation. Here we show that administration of alcohol and excessive voluntary consumption of alcohol induce the activation of the mTORC1-mediated signaling pathway in the nucleus accumbens (NAc) of rodents. We further show that the protein expression levels of GluR1 and Homer, two synaptic proteins whose translation has been shown to be modulated by mTORC1, are up-regulated in the NAc of rodents with a history of excessive alcohol consumption. In addition, our results document that the Food and Drug Administration-approved inhibitor of mTORC1, rapamycin, decreases expression of alcohol-induced locomotor sensitization and place preference, as well as excessive alcohol intake and seeking in preclinical rodent models of alcohol abuse. Together, our results suggest that mTORC1 within the NAc is a contributor to molecular mechanisms underlying alcohol-drinking behaviors. Furthermore, despite its massive health and socioeconomic impact worldwide, pharmacotherapies for alcohol abuse and addiction remain limited. Our data therefore put forward the possibility that targeting the mTORC1 signaling cascade is an innovative and valuable strategy for the treatment of alcohol use and abuse disorders.

26 March 2014 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
JNJérémie Neasta
Jérémie Neasta
SBSegev Barak
Segev Barak
SHSami Ben Hamida
Sami Ben Hamida
DRDorit Ron
Dorit Ron
The mammalian (or mechanistic) target of rapamycin (mTOR) complex 1 (mTORC1) is a serine and threonine kinase that regulates cell growth, survival, and proliferation. mTORC1 is a master controller of the translation of a subset of mRNAs. In the central nervous system mTORC1 plays a crucial role in mechanisms underlying learning and memory by controlling synaptic protein synthesis. Here, we review recent evidence suggesting that the mTORC1 signaling pathway promotes neuroadaptations following exposure to a diverse group of drugs of abuse including stimulants, cannabinoids, opiates, and alcohol. We further describe potential molecular mechanisms by which drug‐induced mTORC1 activation may alter brain functions. Finally, we propose that mTORC1 is a focal point shared by drugs of abuse to mediate drug‐related behaviors such as reward seeking and excessive drug intake, and offer future directions to decipher the contribution of the kinase to mechanisms underlying addiction. image Recent studies suggesting that exposure to diverse classes of drugs of abuse as well as exposure to drug‐associated memories lead to mTORC1 kinase activation in the limbic system. In turn, mTORC1 controls the onset and the maintenance of pathological neuroadaptions that underlie several features of drug addiction such as drug seeking and relapse. Therefore, we propose that targeting mTORC1 and its effectors is a promising strategy to treat drug disorders.

1 September 2011 in Biological Psychiatry
Verified
Journal Article
Closed access
JNJérémie Neasta
Jérémie Neasta
SHSami Ben Hamida
Sami Ben Hamida
QYQuinn V. Yowell
Quinn V. Yowell
SCSebastien Carnicella
Sebastien Carnicella
DRDorit Ron
Dorit Ron

1 June 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
DHDao-Yao He
Dao-Yao He
JNJérémie Neasta
Jérémie Neasta
DRDorit Ron
Dorit Ron
Scaffolding proteins are major contributors to the spatial and temporal orchestration of signaling cascades and hence cellular functions. RACK1 is a scaffolding protein that plays an important role in the regulation of, and cross-talk between, various signaling pathways. Here we report that RACK1 is a mediator of chromatin remodeling, resulting in an exon-specific expression of the brain-derived neurotrophic factor (BDNF) gene. Specifically, we found that following the activation of the cAMP pathway, nuclear RACK1 localizes at the promoter IV region of the BDNF gene by its association with histones H3 and H4, leading to the dissociation of the transcription repressor methyl-CpG-binding protein 2 (MeCP2) from the promoter, resulting in the acetylation of histone H4. These chromatin modifications lead to the activation of the promoter and to the subsequent promoter-controlled transcription of BDNF exon IV. Our findings expand our knowledge regarding the function of scaffolding proteins such as RACK1. Furthermore, this novel mechanism for the regulation of exon-specific expression of the BDNF gene by RACK1 could have implications on the neuronal functions of the growth factor including synaptic plasticity, learning, and memory.